This topic contains a solution. Click here to go to the answer

Author Question: A properly designed single-case interaction design will evaluate the effects of each treatment (B ... (Read 74 times)

D2AR0N

  • Hero Member
  • *****
  • Posts: 561
A properly designed single-case interaction design will evaluate the effects of each treatment (B and C) alone and in combination. Which of the following will allow this?
 
  a. Participant 1: A-B-A-B-BC
  Participant 2: A-C-A-C-BC
  b. Participant 1: A-B-A-BC
  Participant 2: A-C-A-BC
  c. Participant 1: A-B-A-B-BC
  d. Participant 1: A-C-A-C-BC

Question 2

In a between-participants posttest-only design
 
  a. each participant is tested in only one treatment condition.
  b. each participant experiences all treatment conditions.
  c. pairs of matched participants experience the same treatment conditions.
  d. all of the above.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Koolkid240

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

A

Answer to Question 2

A





 

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library